Işgör Yasemin G, Kiliç Zuhal, Olgen Süreyya
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, Ankara, Turkey.
Chem Biol Drug Des. 2008 Dec;72(6):599-604. doi: 10.1111/j.1747-0285.2008.00734.x.
The pp60(c-Src) is one of the ubiquitously expressed Src family kinases and has important functions in malignant cells, including regulation of cell division, growth factor signaling, and movement. Therefore, investigating new small molecule inhibitors of pp60(c-Src) is important to discover and develop novel therapeutics for cancer and metastasis. Moreover, some of the small molecule inhibitors that do not qualify for therapeutic use may become very useful tool to explore the role of Src kinase in normal cells as well as in a variety of disease models. Our continuous efforts to find novel inhibitors of pp60(c-Src) aimed for therapeutic and research use, we synthesized newly designed aminomethylindole derivatives as novel small molecule inhibitors and investigated their inhibitory effect on pp60(c-Src) tyrosine kinase. Here, we report one potential inhibitor of the pp60(c-Src) from five active molecules of all nine compounds, which were synthesized and screened for the biological activity of the molecules against pp60(c-Src) target.
pp60(c-Src)是一种广泛表达的Src家族激酶,在恶性细胞中具有重要功能,包括调节细胞分裂、生长因子信号传导和细胞运动。因此,研究新型的pp60(c-Src)小分子抑制剂对于发现和开发癌症及转移的新型治疗方法具有重要意义。此外,一些不符合治疗用途的小分子抑制剂可能成为探索Src激酶在正常细胞以及各种疾病模型中作用的非常有用的工具。我们持续努力寻找用于治疗和研究的新型pp60(c-Src)抑制剂,合成了新设计的氨基甲基吲哚衍生物作为新型小分子抑制剂,并研究了它们对pp60(c-Src)酪氨酸激酶的抑制作用。在此,我们报告了从九种化合物的五个活性分子中筛选出的一种潜在的pp60(c-Src)抑制剂,这些化合物已合成并针对其对pp60(c-Src)靶点的生物活性进行了筛选。